Home/Filings/4/0001567619-19-020399
4//SEC Filing

Rao Madduri Ravin 4

Accession 0001567619-19-020399

CIK 0001636282other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 5:21 PM ET

Size

5.5 KB

Accession

0001567619-19-020399

Insider Transaction Report

Form 4
Period: 2019-11-01
Rao Madduri Ravin
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-11-01+130,000130,000 total
    Exercise: $8.24Exp: 2029-10-31Common Stock (130,000 underlying)
Footnotes (1)
  • [F1]The options will vest as to 1/4th of the total shares on November 1, 2020, and then 1/48th of the shares monthly thereafter, such that the option is fully vested on November 1, 2023, subject to the Reporting Person's provision of service to the issuer on each vesting date.

Documents

1 file

Issuer

Aeglea BioTherapeutics, Inc.

CIK 0001636282

Entity typeother

Related Parties

1
  • filerCIK 0001792006

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 5:21 PM ET
Size
5.5 KB